Condition: Type 1 Diabetes (T1D) · Sponsor: Second Xiangya Hospital of Central South University
The GLITTER study is comprised of four key components: Team, Technology, Education, and Peer Resources. The aim of the GLITTER Study is to improve the metabolic control rate in patients with type 1 diabetes through a comprehensive management approach.
This description comes directly from the study's public registry record.
Xia Li · +86 13974885753 · lixia2014@vip.163.com
Always discuss trial participation with your own doctor first.
| Department of Endocrinology and Metabolism, Peking University People's Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| Department of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen University | Guangzhou, Guangdong, China | Recruiting |
| Department of Endocrinology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University | Shenzhen, Guangdong, China | Recruiting |
| Endocrinology and Metabolism Center, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology | Luoyang, Henan, China | Recruiting |
| Institute of Metabolism and Endocrinology, Second Xiangya Hospital of Centra South University | Changsha, Hunan, China | Recruiting |
| Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University | Nanjing, Jiangsu, China | Recruiting |
| Department of Endocrinology and Metabolism, Institute of Endocrinology, The First Affiliated Hospital of China Medical University | Shenyang, Liaoning, China | Recruiting |
| Department of Endocrinology and Metabolism, Laboratory of Diabetes and metabolism research, West China Hospital, Sichuan University | Chengdu, Sichuan, China | Recruiting |
| Department of Endocrinology, Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07097805